BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10919211)

  • 1. [Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].
    Durand F; Danic B; Tardivel R; Semana G; Gouezec H; Martinot M; Marcellin P; Beauplet A
    Transfus Clin Biol; 2000 Jun; 7(3):242-50. PubMed ID: 10919211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute nosocomial HCV infection detected by NAT of a regular blood donor.
    Larke B; Hu YW; Krajden M; Scalia V; Byrne SK; Boychuk LR; Klein J
    Transfusion; 2002 Jun; 42(6):759-65. PubMed ID: 12147030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HCV viral load in anti-HCV-reactive donors and infectivity for their recipients.
    Operskalski EA; Mosley JW; Tobler LH; Fiebig EW; Nowicki MJ; Mimms LT; Gallarda J; Phelps BH; Busch MP; ;
    Transfusion; 2003 Oct; 43(10):1433-41. PubMed ID: 14507276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus: routes of infection and genotypes in a cohort of anti-HCV-positive French blood donors.
    Elghouzzi MH; Bouchardeau F; Pillonel J; Boiret E; Tirtaine C; Barlet V; Moncharmont P; Maisonneuve P; du Puy-Montbrun MC; Lyon-Caen D; Couroucé AM
    Vox Sang; 2000; 79(3):138-44. PubMed ID: 11111231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
    Hitzler WE; Runkel S
    Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
    Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
    J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients.
    Busch MP
    Transfus Clin Biol; 2001 Jun; 8(3):200-6. PubMed ID: 11499958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women.
    Kumar RM; Frossad PM; Hughes PF
    Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):177-82. PubMed ID: 9447371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus (HCV) infection in bone marrow transplant patients after transfusions from anti-HCV-positive blood donors.
    Shuhart MC; Myerson D; Spurgeon CL; Bevan CA; Sayers MH; McDonald GB
    Bone Marrow Transplant; 1996 Apr; 17(4):601-6. PubMed ID: 8722362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations.
    Lee SR; Peterson J; Niven P; Bahl C; Page E; DeLeys R; Giordano-Schmidt D; Baggett D; Green G
    Vox Sang; 2001 Jan; 80(1):19-23. PubMed ID: 11339063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
    O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
    Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.
    Foberg U; Ekermo B; Widell A; Mathiesen U; Fryden A
    Scand J Infect Dis; 1996; 28(1):21-6. PubMed ID: 9122627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
    Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
    Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia.
    de Vera ME; Volk ML; Ncube Z; Blais S; Robinson M; Allen N; Evans R; Weissman J; Baron P; Kore A; Bratton C; Garnett G; Hoang T; Wai P; Villicana R
    Am J Transplant; 2018 Oct; 18(10):2451-2456. PubMed ID: 30040178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.